- Feb 5, 2002
- 166,616
- 56,253
- Country
- United States
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
Experts outline the costs of disregarding the ethical considerations of such research.
WASHINGTON — Former members of the Trump-era National Institutes of Health (NIH) Human Fetal Tissue Research Ethics Advisory Board and a pro-life expert on the topic are speaking out against the Biden administration’s recent decision to remove the requirement that the board review human fetal-tissue research from elective abortions.
In addition to highlighting the importance of ethical considerations, they also pointed out past ethical violations on the part of researchers that demonstrate the continuing need for such a review board.
The NIH said in its announcement, “because the HHS secretary has determined there are no new ethical issues that require special review, HHS is reversing its 2019 decision that all research applications for NIH grants and contracts proposing the use of human fetal tissue from elective abortions be reviewed by an Ethics Advisory Board.”
In its notice, NIH reminded the community of extramural researchers of “expectations to obtain informed consent from the donor for any NIH-funded research using human fetal tissue (NOT-OD-16-033) and of continued obligations to conduct such research only in accord with any applicable federal, state or local laws and regulations, including prohibitions on the payment of valuable consideration for such tissue.”
Continued below.
Fetal-Tissue Research: Bioethicists Weigh in on Biden Administration’s Removal of Restrictions
WASHINGTON — Former members of the Trump-era National Institutes of Health (NIH) Human Fetal Tissue Research Ethics Advisory Board and a pro-life expert on the topic are speaking out against the Biden administration’s recent decision to remove the requirement that the board review human fetal-tissue research from elective abortions.
In addition to highlighting the importance of ethical considerations, they also pointed out past ethical violations on the part of researchers that demonstrate the continuing need for such a review board.
The NIH said in its announcement, “because the HHS secretary has determined there are no new ethical issues that require special review, HHS is reversing its 2019 decision that all research applications for NIH grants and contracts proposing the use of human fetal tissue from elective abortions be reviewed by an Ethics Advisory Board.”
In its notice, NIH reminded the community of extramural researchers of “expectations to obtain informed consent from the donor for any NIH-funded research using human fetal tissue (NOT-OD-16-033) and of continued obligations to conduct such research only in accord with any applicable federal, state or local laws and regulations, including prohibitions on the payment of valuable consideration for such tissue.”
Continued below.
Fetal-Tissue Research: Bioethicists Weigh in on Biden Administration’s Removal of Restrictions
